Back to search

Finland· FI-REL-REL54668

Atectura Breezhaler

A indacaterol und mometason product containing indacaterol acetate + mometasone furoate, registered in Finland by Novartis Europharm Limited. The same ATC class is registered in 11 of our 19 countries.

ATC R03AK14

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedAtectura BreezhalerATCR03AK14REGISTER NO.FI-REL-REL54668PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Indacaterol und mometason is registered in 11 of 19 countries.

Countries holding a registration under ATC R03AK14 (indacaterol und mometason), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 7 of them publish a price we can compare per daily dose

Indacaterol und mometason · ATC R03AK14

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of indacaterol und mometason costs, country by country.

Normalised to the WHO defined daily dose (0.15 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Indacaterol und mometason · price per daily dose (0.15 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.85
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Indacaterol acetate + Mometasone furoate
Manufacturer
Novartis Europharm Limited
Country
Finland (FI)
ATC code
R03AK14
ATC class
Indacaterol und Mometason
Defined daily dose
0.15 mg, Inhal
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2221f599-13d7-450d-88ba-61ebb8477d8e
GET /v1/drugs/2221f599-13d7-450d-88ba-61ebb8477d8e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "1",
  "form": "inhalaatiojauhe, kapseli, kova",
  "route": "Inhalaatioon",
  "ddd_unit": "ED",
  "strength": "125 mikrog / 260 mikrog",
  "atc_label": "indakateroli ja mometasoni",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/1/20/1439/009-012",
  "fimea_rel_id": "REL54668",
  "authorised_at": "2020-05-30"
}

See everything about indacaterol und mometason.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.